BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25655994)

  • 21. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury.
    Gao J; Sun Z; Xiao Z; Du Q; Niu X; Wang G; Chang YW; Sun Y; Sun W; Lin A; Bresnahan JC; Maze M; Beattie MS; Pan JZ
    Br J Anaesth; 2019 Dec; 123(6):827-838. PubMed ID: 31623841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of dexmedetomidine pretreatment on the pro- and anti-inflammation systems after spinal cord injury in rats.
    Rong H; Zhao Z; Feng J; Lei Y; Wu H; Sun R; Zhang Z; Hou B; Zhang W; Sun Y; Gu X; Ma Z; Liu Y
    Brain Behav Immun; 2017 Aug; 64():195-207. PubMed ID: 28302458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylpuerarin increases cell viability and reduces apoptosis in rat hippocampal neurons following oxygen‑glucose deprivation/reperfusion.
    Liu DM; Wang ZH; Liu L; Zhang XM; Lou FL
    Mol Med Rep; 2013 Nov; 8(5):1453-9. PubMed ID: 24026460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antioxidant effect of dexmedetomidine on testicular ischemia-reperfusion injury.
    Tuglu D; Yuvanc E; Yilmaz E; Gencay IY; Atasoy P; Kisa U; Batislam E
    Acta Cir Bras; 2015 Jun; 30(6):414-21. PubMed ID: 26108030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexmedetomidine protects against ischemia-reperfusion injury in rat skeletal muscle.
    Dong X; Xing Q; Li Y; Han X; Sun L
    J Surg Res; 2014 Jan; 186(1):240-5. PubMed ID: 24007817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexmedetomidine Confers Protection Against Neuronal Oxygen Glucose Deprivation-Reperfusion by Regulating SIRT3 Mediated Autophagy.
    Fu Z; Pang Z; He L; Zhang L; Fan Y; Zhao C; Yang J
    Neurochem Res; 2022 Nov; 47(11):3490-3505. PubMed ID: 36042140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats.
    Ucak A; Onan B; Güler A; Sahin MA; Kılıçkaya O; Oztaş E; Uysal B; Arslan S; Yılmaz AT
    Ann Vasc Surg; 2011 Jul; 25(5):686-95. PubMed ID: 21724106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury in rabbits.
    Fang B; Wang H; Sun XJ; Li XQ; Ai CY; Tan WF; White PF; Ma H
    J Vasc Surg; 2013 Oct; 58(4):1043-52. PubMed ID: 23478501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion.
    Li Q; Chen C; Chen X; Han M; Li J
    Life Sci; 2018 Aug; 207():1-8. PubMed ID: 29729264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin's Beta Common Receptor Mediates Neuroprotection in Spinal Cord Neurons.
    Foley LS; Fullerton DA; Mares J; Sungelo M; Weyant MJ; Cleveland JC; Reece TB
    Ann Thorac Surg; 2017 Dec; 104(6):1909-1914. PubMed ID: 29100648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexmedetomidine-Mediated Prevention of Renal Ischemia-Reperfusion Injury Depends in Part on Cholinergic Anti-Inflammatory Mechanisms.
    Ma J; Chen Q; Li J; Zhao H; Mi E; Chen Y; Yi B; Ning J; Ma D; Lu K; Gu J
    Anesth Analg; 2020 Apr; 130(4):1054-1062. PubMed ID: 30346356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of angiotensin II type-1 receptor blockade with olmesartan on spinal cord ischemia-reperfusion injury: an experimental study on rats.
    Güler A; Sahin MA; Ucak A; Onan B; Inan K; Oztaş E; Arslan S; Uysal B; Demirkiliç U; Tatar H
    Ann Vasc Surg; 2010 Aug; 24(6):801-8. PubMed ID: 20638619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexmedetomidine inhibits apoptosis of astrocytes induced by oxygen-glucose deprivation via targeting JAK/STAT3 signal pathway.
    Feng P; Zhang A; Su M; Cai H; Wang X; Zhang Y
    Brain Res; 2021 Jan; 1750():147141. PubMed ID: 33017590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical efficacy of Dexmedetomidine on spinal cord injury provoked oxidative renal damage.
    Shou-Shi W; Ting-Ting S; Ji-Shun N; Hai-Chen C
    Ren Fail; 2015 Aug; 37(7):1190-7. PubMed ID: 26181644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury.
    Kiziltepe U; Turan NN; Han U; Ulus AT; Akar F
    J Vasc Surg; 2004 Jul; 40(1):138-45. PubMed ID: 15218474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical indicators of paraplegia underplay universal spinal cord neuronal injury from transient aortic occlusion.
    Bell MT; Puskas F; Bennett DT; Cleveland JC; Herson PS; Mares JM; Meng X; Weyant MJ; Fullerton DA; Brett Reece T
    Brain Res; 2015 Aug; 1618():55-60. PubMed ID: 26005132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excessively high systemic blood pressure in the early phase of reperfusion exacerbates early-onset paraplegia in rabbit aortic surgery.
    Pokhrel B; Hasegawa T; Izumi S; Ohmura A; Munakata H; Okita Y; Okada K
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):400-7. PubMed ID: 20537355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of dexmedetomidine against oxidative and tubular damage induced by renal ischemia reperfusion in rats.
    Cakir M; Polat A; Tekin S; Vardi N; Taslidere E; Rumeysa Duran Z; Tanbek K
    Ren Fail; 2015 May; 37(4):704-8. PubMed ID: 25687385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective Effects Against Cerebral Ischemic Injury Exerted by Dexmedetomidine via the HDAC5/NPAS4/MDM2/PSD-95 Axis.
    Lv H; Li Y; Cheng Q; Chen J; Chen W
    Mol Neurobiol; 2021 May; 58(5):1990-2004. PubMed ID: 33411316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexmedetomidine Protects Against Oxygen-Glucose Deprivation-Induced Injury Through Inducing Astrocytes Autophagy via TSC2/mTOR Pathway.
    Zhu C; Zhou Q; Luo C; Chen Y
    Neuromolecular Med; 2020 Jun; 22(2):210-217. PubMed ID: 31654225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.